Literature DB >> 15473177

Pyruvate dehydrogenase deficiency presenting as dystonia in childhood.

R A Head1, C G E L de Goede, R W N Newton, J H Walter, M A McShane, R M Brown, G K Brown.   

Abstract

Two individuals with pyruvate dehydrogenase (PDH) deficiency due to missense mutations in the gene for the E1alpha subunit (PDHA1) presented during childhood with dystonia. The first patient, a male, presented at age 4 years with dystonia affecting the lower limbs, which responded to treatment with combined carbidopa and levodopa. The second patient, a female, was first investigated at age 6 years because of a dystonic gait disorder. In both patients, the main clue to the biochemical diagnosis was a raised concentration of lactate in the cerebrospinal fluid. PDH activity was significantly reduced in cultured fibroblasts in both cases. Dystonia is a previously unrecognized major manifestation of PDH deficiency and is of particular interest as the mutations in the PDHA1 gene in these patients have both been identified previously in individuals with typical presentations of the condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15473177     DOI: 10.1017/s0012162204001197

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  11 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

3.  Pyruvate dehydrogenase-e1α deficiency presenting as recurrent demyelination: an unusual presentation and a novel mutation.

Authors:  Pratibha Singhi; Linda De Meirleir; Willy Lissens; Sunit Singhi; Arushi Gahlot Saini
Journal:  JIMD Rep       Date:  2013-02-12

Review 4.  Genetic updates on paroxysmal dyskinesias.

Authors:  James Y Liao; Philippe A Salles; Umar A Shuaib; Hubert H Fernandez
Journal:  J Neural Transm (Vienna)       Date:  2021-04-30       Impact factor: 3.575

5.  Treatment of generalized dystonia.

Authors:  Naomi Lubarr; Susan Bressman
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

6.  Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency.

Authors:  Francois-G Debray; Marie Lambert; Michel Vanasse; Jean-Claude Decarie; Jessie Cameron; Valeriy Levandovskiy; Brian H Robinson; Grant A Mitchell
Journal:  Eur J Pediatr       Date:  2006-03-22       Impact factor: 3.183

Review 7.  Experimental therapeutics for dystonia.

Authors:  H A Jinnah; Ellen J Hess
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 8.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 9.  Genetic Dystonia-ataxia Syndromes: Clinical Spectrum, Diagnostic Approach, and Treatment Options.

Authors:  Malco Rossi; Bettina Balint; Patricio Millar Vernetti; Kailash P Bhatia; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2018-07-03

Review 10.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.